
Krish Patel, MD, Swedish Medical Center
Advertisement
Articles by Krish Patel, MD, Swedish Medical Center
Advertisement
Latest Updated Articles
Selecting a BTKi for Relapsed MCL TreatmentFebruary 9th 2021
Lenalidomide and Bortezomib for Mantle Cell LymphomaJanuary 26th 2021
BTK Inhibitors for Relapsed MCL: Important ConsiderationsFebruary 9th 2021
Emerging BTK Inhibitors in Mantle Cell LymphomaFebruary 23rd 2021
Novel Therapies in the Pipeline in Mantle Cell LymphomaMarch 2nd 2021
CAR T-Cell Therapy for R/R Mantle Cell LymphomaFebruary 16th 2021
Advertisement
Advertisement
Trending on OncLive
1
ctDNA Status Has Strong Prognostic Value, Outperforming pCR Status, in Early TNBC
2
FDA Grants Priority Review to Giredestrant for ER-Positive Early Breast Cancer
3
Dato-DXd Hits Key Secondary Efficacy End Points in First-Line TNBC
4
Retrospective Data Show Zanubrutinib May Less AFib Burden in Real-World CLL
5














